Apoptosis and nuclear shapes in benign prostate hyperplasia and prostate adenocarcinoma: Comparison with and relation to Gleason score

International Journal of Urology

Volumn 6, Issue 1, 1999, Pages 13-18

  Choi, Nak Gyeu ^a,b   Sohn, Jin Hee ^a   Park, Hung Won ^a   Jung, Tae Young ^a  

^a Hallym College   (South Korea)

^b Hangang Sungshim Hospital   (South Korea)

Author keywords

Apoptosis; Benign prostate hyperplasia; Nuclear roundness; Nuclear size; Prostate cancer

Indexed keywords

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL; CELL HYPERPLASIA; CELL NUCLEUS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE HYPERTROPHY; RETROSPECTIVE STUDY; SCORING SYSTEM;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; APOPTOSIS; CELL NUCLEUS; DIAGNOSIS, DIFFERENTIAL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 0033507764     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.1999.06116.x     Document Type: Article

References (27)

1. 1 Ellis RE, Yuan J, Horvitz R. Mechanisms and functions of cell death. Annu. Rev. Cell Biol. 1991; 7: 663-98.
2. 2 Harris DR, Savill J. Apoptosis and prostate. Br. J. Urol. 1995; 75 (Suppl. 1): 27-33.
3. 3 Wyllie AH. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev. 1992; 11: 95-103.
4. 4 Carson DA, Ribeiro JM. Apoptosis and disease. Lancet 1993; 341: 1251-4.
5. 5 Issacs JT. Antagonistic effect of androgen on prostatic cell death. Prostate 1984; 5: 545-57.
6. 6 Kyprianou N, Issacs JT. Activation of programmed cell death in rat ventral prostate after castration. Endocrinoogy. 1988; 122: 552-62.
7. 7 Kerr JFR, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. Br. J. Cancer 1972; 26: 239-57.
8. 8 Savill J, Fadok V, Henson P, Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol. Today 1993; 14: 131-6.
9. 9 Artacho-Perula E, Roldan-Villalobos R, Salas-Molina J, Vaamonde-Lemos R. Histomorphometry of normal and abnormal cervical samples. Anal. Quant. Cytol. Histol. 1993; 15: 290-7.
10. 10 Taylor CR, Shi SR, Chaiwun B, Young L, Imam SA, Cote RJ. Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections. Hum. Pathol. 1994; 25: 263-70.
11. 11 Cotter TG, Lennon SV, Glynn JG, Martin SJ. Cell death via apoptosis and its relationship to growth, development and differentiation of both tumor and normal cells. Anticancer Res. 1990; 10: 1153-60.
12. 12 Montironi R, Galluzzi CM, Scarpelli M, Giannulis I, Diamanti L. Occurrence of cell death (apoptosis) in prostatic intra-epithelial neoplasia. Virchows Arch. A Pathol. Anat. 1993; 423: 351-7.
13. 13 Montironi R, Galluzzi CM, Fabris G. Apoptotic bodies in prostate intra-epithelial neoplasia and prostatic adenocarcinoma following total androgen ablation. Pathol. Res. Pract. 1995; 191: 873-80.
14. 14 Bostwick DG, Pacelli A, Lopez-Beltran A. Molecular biology of prostatic intraepithelial neoplasia. Prostate 1996; 29: 117-36.
15. 15 Egawa S, Kadman D, Miller GJ. Alterations in mRNA levels for growth related genes following transplantation into castrated hosts in oncogene-induced clonal mouse prostate carcinoma. Mol. Carcinog. 1992; 5: 52-61.
16. 16 Aihara M, Truong LD, Dunn JK, Wheeler TM, Scardino PT, Thompson TC. Frequency of apoptotic bodies positively correlates with Gleason grade in prostatic cancer. Hum. Pathol. 1994; 25: 797-801.
17. 17 Gaffney EF. The extent of apoptosis in different types of high grade prostatic carcinoma. Histopathology 1994; 25: 269-73.
18. 18 Kyprianou N, English HF, Issacs JT. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res. 1990; 50: 3748-53.
19. 19 Westin P, Stattin P, Damber JE, Berg A. Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors. AJP 1995; 146: 1368-75.
20. 20 Montpetit M, Abrahams P, Clark AF, Tenniswood M. Androgen-independent epithelial cells of the rat ventral prostate. Prostate 1988; 12: 13-28.
21. 21 Petein M, Michel P, Velthoven RV et al. Morphonuclear relationship between prostatic intraepithelial neoplasia and cancers as assessed by digital cell image analysis. Am. J. Clin. Pathol. 1991; 96: 628-38.
22. 22 Gleason DF, Mellinger GT and The Veterans Administrative Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J. Urol. 1974; 111: 58-64.
23. 23 Tannenbaum M, Tannenbaum S, DeSanctis PN, Olsson CA. Prognostic significance of nucleolar surface area in prostate cancer. Urology 1982; 14: 546-51.
24. 24 Gaeta JF, Asirwatham JE, Miller G, Murphy G. Histologic grading of primary prostatic cancer: A new approach to an old problem. J. Urol. 1980; 123: 689-93.
25. 25 Diamond DA, Berry SJ, Umbricht C, Jewett HJ, Coffey DS. Computerized image analysis of nuclear shape as a prognostic factor for prostatic cancer. Prostate 1982; 3: 321-32.
26. 26 Diamond DA, Berry SJ, Jewett HJ, Eggleston JC, Coffey DS. A new method to assess metastatic potential of human prostate cancer: Relative nuclear roundness. J. Urol. 1982; 128: 729-33.
27. 27 Epstein JI, Berry SJ, Eggelston JC. Nuclear roundness factor: A predictor of progression in untreated stage A2 prostate cancer. Cancer 1984; 15: 1666-71.